Agenus (AGEN) Projected to Post Earnings on Tuesday

Agenus (NASDAQ:AGEN) is projected to post its quarterly earnings results before the market opens on Tuesday, March 11th. Analysts expect Agenus to post earnings of ($2.36) per share and revenue of $30.09 million for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

Agenus Price Performance

Shares of AGEN opened at $2.35 on Friday. Agenus has a 52-week low of $2.31 and a 52-week high of $19.69. The company has a market capitalization of $55.13 million, a PE ratio of -0.21 and a beta of 1.23. The stock has a fifty day simple moving average of $3.27 and a two-hundred day simple moving average of $3.91.

Analyst Ratings Changes

Separately, HC Wainwright reiterated a “neutral” rating on shares of Agenus in a report on Wednesday, January 22nd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $10.00.

Agenus Company Profile

Agenus Inc, a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies.